Stay updated on Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial page.

Latest updates to the Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial page
- Check5 days agoChange DetectedA new Revision: v3.4.1 was added and Revision: v3.4.0 was removed in the record history, reflecting an update to the page's version metadata.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded revision v3.3.4 and removed revision v3.3.3 from the Record History.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a new Revision: v3.3.3 and removed HHS Vulnerability Disclosure as well as Revision: v3.3.2 from the page history.SummaryDifference0.2%

- Check77 days agoChange DetectedA new revision entry v3.3.2 was added to the history, and the previous v3.2.0 entry was removed.SummaryDifference0.1%

- Check84 days agoChange DetectedThe government funding status notice banner on the page has been removed.SummaryDifference0.6%

- Check106 days agoChange DetectedA new version entry (Version 13, 2021-04-12) was added to the Record History, while the rest of the page content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial page.